Strategic Partnerships Stratatech has recent collaboration momentum with academic and military-affiliated institutions (University of Wisconsin-Milwaukee, UW-Madison, Armed Forces Institute of Pathology, and Waisman Clinical Biomanufacturing Facility) which signals openness to joint development, contract research, and scalable biomanufacturing partnerships.

Regenerative Medicine Focus Company positioning around cell-based therapeutics for severe burns and complex skin defects suggests opportunities to offer specialized biomanufacturing services, regulatory support, and clinical trial workflows tailored to regenerative medicine stakeholders.

Acquisition & Access Former parent linkage to Mallinckrodt indicates legacy financing and potential access to established distribution, regulatory, and clinical networks, which can be leveraged for co-development programs and larger grant-funded initiatives.

Mid-Sized Scale With a workforce in the 51-200 range and annual revenue in the 10–25 million band, Stratatech represents a growth-stage partner option for niche biotech vendors, contract manufacturers, and specialty suppliers seeking scalable collaboration without enterprise-level procurement friction.

Technology Stack Fit Existing tech footprint (ASP.NET, jQuery, Modernizr, Google Analytics, Google Maps) aligns with web-enabled partnerships, patient/population data collaboration, and digital project management for joint ventures, enabling efficient coordination and data sharing.